Publications by authors named "Angel Sanchez-Iglesias"
Article Synopsis
- - The study focused on identifying imaging biomarker profiles from MRIs of prostate cancer (PCa) patients to predict their risk of biochemical recurrence (BCR) and help guide treatment decisions.
- - Researchers analyzed MRI data from 128 patients who received neoadjuvant therapy, finding that certain radiomic features related to heterogeneity could differentiate between patients with varying prognosis and those who experienced BCR.
- - The combined imaging and clinical data led to significantly improved predictions of BCR risk, indicating that utilizing region-specific imaging profiles allows for better identification of high-risk patients.
Purpose: Ablative treatment of oligometastases has shown survival benefit with certain tumors, although these effects still are to be demonstrated in prostate cancer.
Materials And Methods: We analysed the toxicity and clinical control results obtained in patients with bone-only oligometastatic prostate cancer treated with stereotactic ablative radiotherapy (SABR). Retrospective study on patients with metachronous oligoprogression and synchronous de novo bone-only oligometastatic prostate cancer treated with SABR and androgen deprivation therapy.
Background: Care overburden makes it difficult to perform comprehensive geriatric assessments (CGAs) in oncology settings. We analyzed if screening tools modified radiotherapy in oncogeriatric patients.
Methods: Patients ≥ 65 years, irradiated between December 2020 and March 2021 at the Hospital Provincial de Castellón, completed the frailty G8 and estimated survival Charlson questionnaires.
Background: Most available prognostic nomograms in metastatic castration-resistant prostate cancer (mCRPC) are derived from datasets not representative of the current treatment landscape. A prognostic nomogram for first-line mCRPC treatment was developed from patients treated in the PREVAIL study.
Objective: To validate the Armstrong model in the COU-AA-302 trial.
Hypoxia is related to poor prognosis because it is associated to chemo- and radioresistance. During recent years the evolution of imaging methods like PET/CT and MRI has meant the appearance of new perspectives with direct implications in radiation therapy. We discuss previous experiences in staging, planning and in the follow-up process with these techniques for measuring tumour hypoxia.
View Article and Find Full Text PDF